Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:1847-1850

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neubauer, S.
Right arrow Articles by Wallimann, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neubauer, S.
Right arrow Articles by Wallimann, T.
Related Collections
Right arrow Pathophysiology
Right arrow Heart failure - basic studies

(Circulation. 1999;100:1847-1850.)
© 1999 American Heart Association, Inc.


Brief Rapid Communications

Downregulation of the Na+-Creatine Cotransporter in Failing Human Myocardium and in Experimental Heart Failure

Stefan Neubauer, MD; Helga Remkes; Matthias Spindler, MD; Michael Horn, PhD; Frank Wiesmann, MD; Jürgen Prestle, PhD; Bernd Walzel; Georg Ertl, MD; Gerd Hasenfuss, MD; Theo Wallimann, PhD

From the Medizinische Universitätsklinik Würzburg (S.N., H.R., M.S., M.H., F.W., G.E.) and the Abteilung für Molekulare Kardiologie, Göttingen University (J.P., G.H.), Germany, and the Institute for Cell Biology, ETH-Hönggerberg, Zürich, Switzerland (B.W., T.W.).

Correspondence to Stefan Neubauer, MD, Medizinische Universitätsklinik, Josef-Schneider-Straße 2, 97080 Würzburg, FRG. E-mail s.neubauer{at}mail.uni-wuerzburg.de

Background—The failing myocardium is characterized by depletion of phosphocreatine and of total creatine content. We hypothesized that this is due to loss of creatine transporter protein.

Methods and Results—Creatine transporter protein was quantified in nonfailing and failing human myocardium (explanted hearts with dilated cardiomyopathy [DCM; n=8] and healthy donor hearts [n=8]) as well as in experimental heart failure (residual intact left ventricular tissue, rats 2 months after left anterior descending coronary artery ligation [MI; n=8] or sham operation [sham; n=6]) by Western blotting. Total creatine content was determined by high-performance liquid chromatography. Donor and DCM hearts had total creatine contents of 136.4±6.1 and 68.7±4.6 nmol/mg protein, respectively (*P<0.05); creatine transporter protein was 25.4±2.2 optical density units in donor and 17.7±2.5 in DCM (*P<0.05). Total creatine was 87.5±4.2 nmol/mg protein in sham and 65.7±4.2 in MI rats (*P<0.05); creatine transporter protein was 139.0±8.7 optical density units in sham and 82.1±4.0 in MI (*P<0.05).

Conclusions—Both in human and in experimental heart failure, creatine transporter protein content is reduced. This mechanism may contribute to the depletion of creatine compounds and thus to the reduced energy reserve in failing myocardium. This finding may have therapeutic implications, suggesting a search for treatment strategies targeted toward creatine transport.


Key Words: sodium • creatine • myocardium • heart failure




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Wu, J. Zhang, and D. A. Beard
Experimentally observed phenomena on cardiac energetics in heart failure emerge from simulations of cardiac metabolism
PNAS, April 28, 2009; 106(17): 7143 - 7148.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. S. Ingwall
Energy metabolism in heart failure and remodelling
Cardiovasc Res, February 15, 2009; 81(3): 412 - 419.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. J. Eisen
Exercise Training and Myocardial Energetics in Patients With Heart Failure: When More Is Less
J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1892 - 1895.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Feygin, A. Mansoor, P. Eckman, C. Swingen, and J. Zhang
Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1772 - H1780.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Lamberts, E. Caldenhoven, M. Lansink, G. Witte, R. J. Vaessen, J. A. St Cyr, and G. J. M. Stienen
Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1869 - H1876.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Peluffo and R. Radi
Biochemistry of protein tyrosine nitration in cardiovascular pathology
Cardiovasc Res, July 15, 2007; 75(2): 291 - 302.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Neubauer
The Failing Heart -- An Engine Out of Fuel
N. Engl. J. Med., March 15, 2007; 356(11): 1140 - 1151.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. V. Naumova, V. P. Chacko, R. Ouwerkerk, L. Stull, E. Marban, and R. G. Weiss
Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H837 - H843.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Fan, D. A. Iacobas, D. Zhou, Q. Chen, J. K. Lai, O. Gavrialov, and G. G. Haddad
Gene expression and phenotypic characterization of mouse heart after chronic constant or intermittent hypoxia
Physiol Genomics, August 11, 2005; 22(3): 292 - 307.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. G. Weiss, G. Gerstenblith, and P. A. Bottomley
ATP flux through creatine kinase in the normal, stressed, and failing human heart
PNAS, January 18, 2005; 102(3): 808 - 813.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. S. Ingwall and R. G. Weiss
Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function
Circ. Res., July 23, 2004; 95(2): 135 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. Ventura-Clapier, A. Garnier, and V. Veksler
Energy metabolism in heart failure
J. Physiol., February 15, 2004; 555(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Nakae, K. Mitsunami, T. Omura, T. Yabe, T. Tsutamoto, S. Matsuo, M. Takahashi, S. Morikawa, T. Inubushi, Y. Nakamura, et al.
Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1587 - 1593.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. J. Brault, K. A. Abraham, and R. L. Terjung
Muscle creatine uptake and creatine transporter expression in response to creatine supplementation and depletion
J Appl Physiol, June 1, 2003; 94(6): 2173 - 2180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Boehm, S. Chan, M. Monfared, T. Wallimann, K. Clarke, and S. Neubauer
Creatine transporter activity and content in the rat heart supplemented by and depleted of creatine
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E399 - E406.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Scheubel, M. Tostlebe, A. Simm, S. Rohrbach, R. Prondzinsky, F. N. Gellerich, R.-E. Silber, and J. Holtz
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression
J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2174 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. S. Queiroz, Y. Shao, D. A. Berkich, K. F. Lanoue, and F. Ismail-Beigi
Thyroid hormone regulation of cardiac bioenergetics: role of intracellular creatine
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2527 - H2533.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M J Peral, M Garcia-Delgado, M L Calonge, J M Duran, M C De La Horra, T Wallimann, O Speer, and A A Ilundain
Human, rat and chicken small intestinal Na+-Cl--creatine transporter: functional, molecular characterization and localization
J. Physiol., November 15, 2002; 545(1): 133 - 144.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Beer, T. Seyfarth, J.o. Sandstede, W. Landschutz, C. Lipke, H. Kostler, M. von Kienlin, K. Harre, D. Hahn, and S. Neubauer
Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy
J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1267 - 1274.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Walzel, O. Speer, E. Zanolla, O. Eriksson, P. Bernardi, and T. Wallimann
Novel Mitochondrial Creatine Transport Activity. IMPLICATIONS FOR INTRACELLULAR CREATINE COMPARTMENTS AND BIOENERGETICS
J. Biol. Chem., September 27, 2002; 277(40): 37503 - 37511.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Walzel, O. Speer, E. Boehm, S. Kristiansen, S. Chan, K. Clarke, J. P. Magyar, E. A. Richter, and T. Wallimann
New creatine transporter assay and identification of distinct creatine transporter isoforms in muscle
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E390 - E401.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Spindler, R. Niebler, H. Remkes, M. Horn, T. Lanz, and S. Neubauer
Mitochondrial creatine kinase is critically necessary for normal myocardial high-energy phosphate metabolism
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H680 - H687.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. Hespel, B. Op't Eijnde, M. V. Leemputte, B. Urso, P. L Greenhaff, V. Labarque, S. Dymarkowski, P. V. Hecke, and E. A Richter
Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans
J. Physiol., October 15, 2001; 536(2): 625 - 633.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Horn, H. Remkes, H. Stromer, C. Dienesch, and S. Neubauer
Chronic Phosphocreatine Depletion by the Creatine Analogue {beta}-Guanidinopropionate Is Associated With Increased Mortality and Loss of ATP in Rats After Myocardial Infarction
Circulation, October 9, 2001; 104(15): 1844 - 1849.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. M. Persky and G. A. Brazeau
Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate
Pharmacol. Rev., May 11, 2001; (2001) 1.
[Abstract] [Full Text]


Home page
CirculationHome page
Y. Ye, G. Gong, K. Ochiai, J. Liu, and J. Zhang
High-Energy Phosphate Metabolism and Creatine Kinase in Failing Hearts : A New Porcine Model
Circulation, March 20, 2001; 103(11): 1570 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. Murphy, G. McConell, D. Cameron-Smith, K. Watt, L. Ackland, B. Walzel, T. Wallimann, and R. Snow
Creatine transporter protein content, localization, and gene expression in rat skeletal muscle
Am J Physiol Cell Physiol, March 1, 2001; 280(3): C415 - C422.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. O.'t Eijnde, B. Ursø, E.A. Richter, P.L. Greenhaff, and P. Hespel
Effect of Oral Creatine Supplementation on Human Muscle GLUT4 Protein Content After Immobilization
Diabetes, January 1, 2001; 50(1): 18 - 23.
[Abstract] [Full Text]


Home page
Journal Watch CardiologyHome page
Creatine Cotransporter Deficient in Heart Failure
Journal Watch Cardiology, December 10, 1999; 1999(1210): 3 - 3.
[Full Text]


Home page
Pharmacol. Rev.Home page
A. M. Persky and G. A. Brazeau
Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate
Pharmacol. Rev., June 1, 2001; 53(2): 161 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. T. Tran, W. Dai, and H. K. Sarkar
Cyclosporin A Inhibits Creatine Uptake by Altering Surface Expression of the Creatine Transporter
J. Biol. Chem., November 10, 2000; 275(46): 35708 - 35714.
[Abstract] [Full Text] [PDF]